Unlocking Urologic Oncology Innovation QuickFire Challenge
Supports innovators designing bladder and prostate cancer therapies and surgical tools through a J&J urologic oncology challenge.
Johnson & Johnson Innovation, in partnership with the American Urological Association (AUA), launched the Unlocking Urologic Oncology Innovation QuickFire Challenge in April 2025 to solicit technologies improving treatment and care for patients with bladder and prostate cancers. The total prize pool reached up to $300,000 distributed across multiple awardees. Each recipient receives cash from the …
Funds innovations in bladder and prostate cancer therapeutics — including local delivery and organ-sparing approaches — and surgical technologies such as focal therapies and improved endoscopic procedures like TURBT.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline